Effect of resveratrol on L-type calcium current in rat ventricular myocytes

Acta Pharmacol Sin. 2006 Feb;27(2):179-83. doi: 10.1111/j.1745-7254.2006.00250.x.

Abstract

Aim: To study the effect of resveratrol on L-type calcium current (I(Ca-L)) in isolated rat ventricular myocytes and the mechanisms underlying these effects.

Methods: I(Ca-L) was examined in isolated single rat ventricular myocytes by using the whole cell patch-clamp recording technique.

Results: Resveratrol (10-40 micromol/L) reduced the peak amplitude of I(Ca-L) and shifted the current-voltage (I-V) curve upwards in a concentration-dependent manner. Resveratrol (10, 20, 40 micromol/L) decreased the peak amplitude of I(Ca-L) from -14.2+/-1.5 pA/pF to -10.5+/-1.5 pA/pF (P<0.05), -7.5+/-2.4 pA/pF (P<0.01), and -5.2+/-1.2 pA/pF (P<0.01), respectively. Resveratrol (40 micromol/L) shifted the steady-state activation curve of I(Ca-L) to the right and changed the half-activation potential (V0.5) from -19.4+/-0.4 mV to -15.4+/-1.9 mV (P<0.05). Resveratrol at a concentration of 40 micromol/L did not affect the steady-state inactivation curve of I(Ca-L), but did markedly shift the time-dependent recovery curve of I(Ca-L) to the right, and slow down the recovery of I(Ca-L) from inactivation. Sodium orthovanadate (Na(3)VO(4); 1 mmol/L), a potent inhibitor of tyrosine phosphatase, significantly inhibited the effects of resveratrol (P<0.01).

Conclusion: Resveratrol inhibited I(Ca-L) mainly by inhibiting the activation of L-type calcium channels and slowing down the recovery of L-type calcium channels from inactivation. This inhibitory effect of resveratrol was mediated by the inhibition of protein tyrosine kinase in rat ventricular myocytes.

MeSH terms

  • Animals
  • Anti-Arrhythmia Agents / administration & dosage
  • Anti-Arrhythmia Agents / pharmacology*
  • Calcium Channels, L-Type / drug effects*
  • Dose-Response Relationship, Drug
  • Heart Ventricles
  • Male
  • Myocytes, Cardiac / metabolism*
  • Patch-Clamp Techniques
  • Protein-Tyrosine Kinases / antagonists & inhibitors
  • Rats
  • Rats, Sprague-Dawley
  • Resveratrol
  • Stilbenes / administration & dosage
  • Stilbenes / pharmacology*
  • Vanadates / pharmacology

Substances

  • Anti-Arrhythmia Agents
  • Calcium Channels, L-Type
  • Stilbenes
  • Vanadates
  • Protein-Tyrosine Kinases
  • Resveratrol